Microsurgical third ventriculocisternostomy as an alternative to ETV: report of two cases

OBJECTIVE: To describe a microsurgical alternative to endoscopic third ventriculocisternostomy. METHODS: Two children with shunt-dependent hydrocephalus and multiple shunt revisions were considered candidates for third ventriculocisternostomy (TVS). Because of slit ventricles, an endoscopic approach was not possible and, therefore, both patients received a microsurgical TVS by a supraorbital approach. RESULTS: In both cases, microsurgical TVS was successful and the patients became shunt free. CONCLUSION: Microsurgical TVS by a supraorbital craniotomy is a viable alternative to endoscopic TVS in selected cases

Evaluation of a novel real-time PCR test based on the ssrA gene for the identification of group B streptococci in vaginal swabs

<p>Abstract</p> <p>Background</p> <p>Despite the implementation of prevention guidelines, early-onset group B streptococci (GBS) disease remains a cause of neonatal morbidity and mortality worldwide. Strategies to identify women who are at risk of transmitting GBS to their infant and the administration of intrapartum antibiotics have greatly reduced the incidence of neonatal GBS disease. However, there is a requirement for a rapid diagnostic test for GBS that can be carried out in a labour ward setting especially for women whose GBS colonisation status is unknown at the time of delivery. We report the design and evaluation of a real-time PCR test (<it>RiboSEQ </it>GBS test) for the identification of GBS in vaginal swabs from pregnant women.</p> <p>Methods</p> <p>The qualitative real-time PCR <it>RiboSEQ </it>GBS test was designed based on the bacterial <it>ssrA </it>gene and incorporates a competitive internal standard control. The analytical sensitivity of the test was established using crude lysate extracted from serial dilutions of overnight GBS culture using the IDI Lysis kit. Specificity studies were performed using DNA prepared from a panel of GBS strains, related streptococci and other species found in the genital tract environment. The <it>RiboSEQ </it>GBS test was evaluated on 159 vaginal swabs from pregnant women and compared with the GeneOhm™ StrepB Assay and culture for the identification of GBS.</p> <p>Results</p> <p>The <it>RiboSEQ </it>GBS test is specific and has an analytical sensitivity of 1-10 cell equivalents. The <it>RiboSEQ </it>GBS test was 96.4% sensitive and 95.8% specific compared to "gold standard" culture for the identification of GBS in vaginal swabs from pregnant women. In this study, the <it>RiboSEQ </it>GBS test performed slightly better than the commercial BD GeneOhm™ StrepB Assay which gave a sensitivity of 94.6% and a specificity of 89.6% compared to culture.</p> <p>Conclusion</p> <p>The <it>RiboSEQ </it>GBS test is a valuable method for the rapid, sensitive and specific detection of GBS in pregnant women. This study also validates the <it>ssrA </it>gene as a suitable and versatile target for nucleic acid-based diagnostic tests for bacterial pathogens.</p

Osteopontin is not required for the development of Th1 responses and viral immunity.

Osteopontin (OPN) has been defined as a key cytokine promoting the release of IL-12 and hence inducing the development of protective cell-mediated immunity to viruses and intracellular pathogens. To further characterize the role of OPN in antiviral immunity, OPN-deficient (OPN-/-) mice were analyzed after infection with influenza virus and vaccinia virus. Surprisingly, we found that viral clearance, lung inflammation, and recruitment of effector T cells to the lung were unaffected in OPN-/- mice after influenza infection. Furthermore, effector status of T cells was normal as demonstrated by normal IFN-gamma production and CTL lytic activity. Moreover, activation and Th1 differentiation of naive TCR transgenic CD4+ T cells by dendritic cells and cognate Ag was normal in the absence of OPN in vitro. Contrary to a previous report, we found that OPN-/- mice mounted a normal immune response to Listeria monocytogenes. In conclusion, OPN is dispensable for antiviral immune responses against influenza virus and vaccinia virus

COMPLEX URBAN SIMULATIONS AND SUSTAINABLE URBAN PLANNING WITH SPATIAL AND SOCIAL IMPLICATIONS

Cities can be seen as complex systems of heterogeneous processes with a high variety of different influences (e.g. social, infrastructural, economic, and political impacts). This especially applies for tasks concerning urban development of existing assets. The optimization of traffic flows, reduction of emissions, improvement of energy efficiency, but also urban climate and landscape planning issues require the involvement of many different actors, balancing different perspectives, and divergent claims. The increasing complexities of planning and decision processes make high demands on professionals of various disciplines, government departments, and municipal decision-makers. In the long term, topics like urban resilience, energy management, risk and resource management have to be taken into account and reflected in future projects, but always related to socio-spatial and governmental aspects. Accordingly, it is important to develop models to be able to understand and analyze the outcomes and effects of governmental measures and planning to the urban environment. Thus, a more systematic approach is needed &ndash; going away from welldefined city models to city system models. The purpose is to describe urban processes not only quantitatively, but to grasp their qualitative complexity and interdependencies, by modeling and simulating existing urban systems. This contribution will present the City System Model (CSM) concept closely related to an Urban Energy Planning use case, will highlight the methodology, and focus on first results and findings from an ongoing interdisciplinary research project and use case to improve the basis of information for decision-makers and politicians about urban planning decisions

Correspondence: C. David Denton, T. W. Boschert, B. A. Bogy, Jr., John C. Stennis, July 15-17, 1957

Senator Stennis discusses cotton legislation and the primary objective of the cotton program.https://scholarsjunction.msstate.edu/jcs-agriculture-correspondence/1072/thumbnail.jp

Segregating GM crops: why a contentious 'risk' issue in Europe?

Since the Europe-wide ‘risk’ controversy over GM crops in the late 1990s, an extra issue has emerged: the prospect that GM material would become inadvertently mixed with non-GM products, which consequently may require a ‘GM’ label under EU law. The stakes for segregating non-GM crops were framed in contending ways. Agbiotech proponents sought to license a biotechnologised nature as an eco-efficiency benefit,while framing admixture risks as an agronomic management problem which needs rules for co-existence. By contrast, biotech critics have foreseen a dangerous disorder of ‘GM contamination’, while framing this prospect as an ever-wider ‘risk’ issue, encompassing threats to human health, the environment and even democratic accountability. These contending frames intensified disputes over the appropriate rules for segregating GM crops from other agricultures. At stake were different visions of the socio-natural order, expressed by different accounts of risk, freedom and desirable futures. Conflicts of accountability took the form of disputes over market freedom versus coercion and unfair burdens on farmers; these concepts framed expert evidence and thus made it more contentious for any ‘science-based policy’, featuring disputes about whether specific management proposals were based on ‘politics rather than science’. For these reasons, biophysical admixture per se cannot entirely explain why the segregation problem became such a contentious ‘risk’ issue; a comprehensive explanation lies in contending policy frames